Skip to main content

BrightSpring Health Services, Inc.

For the period ended Mar 31, 2025. Filed May 2, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 2, 2025

BTSG$72.49+4.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

For the Three Months Ended
March 31,
20252024
Operating activities:
Net income (loss)$29,010$(46,385)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation and amortization42,16148,922
Impairment of long-lived assets3,4111,769
Change in fair value of contingent consideration, net1,698—
Provision for credit losses8,1016,622
Amortization of deferred debt issuance costs2,7494,447
Share-based compensation15,68124,848
Deferred income taxes, net4,031(31,732)
Loss on extinguishment of debt—12,726
(Gain) loss on disposition of fixed assets(287)122
Other161(312)
Change in operating assets and liabilities, net of acquisitions and dispositions:
Accounts receivable(79,449)(115,576)
Prepaid expenses and other current assets23,9738,916
Inventories103,30030,485
Trade accounts payable(53,871)21,605
Accrued expenses8,643(43,430)
Other assets and liabilities(7,714)(1,886)
Net cash provided by (used in) operating activities$101,598$(78,859)
Investing activities:
Purchases of property and equipment$(17,632)$(21,816)
Acquisitions of businesses(6,754)(9,394)
Other195272
Net cash used in investing activities$(24,191)$(30,938)
Financing activities:
Long-term debt borrowings$—$2,566,000
Long-term debt repayments(11,792)(3,359,353)
Proceeds from issuance of common stock on initial public offering, net—656,485
Proceeds from issuance of tangible equity units, net—389,000
Repayments of the Revolving Credit Facility, net(63,300)(50,700)
Payment of debt issuance costs—(42,963)
Repurchase of shares of common stock—(325)
Proceeds from shares issued under share-based compensation plan345—
Taxes paid related to net share settlement of equity awards(2,763)—
Purchase of redeemable noncontrolling interest(5,100)(300)
Payment of financing lease obligations(3,408)(3,081)
Net cash (used in) provided by financing activities$(86,018)$154,763
Net (decrease) increase in cash and cash equivalents(8,611)44,966
Cash and cash equivalents at beginning of period61,25313,071
Cash and cash equivalents at end of period$52,642$58,037
Cash and cash equivalents included in assets held for sale at end of period3052,494
Cash and cash equivalents included in continuing operations at end of period$52,337$55,543

Condensed Consolidated Statements of Cash Flows (continued)

For the Three Months Ended
March 31,
20252024
Supplemental disclosures of cash flow information:
Cash paid for:
Interest, net$53,799$60,282
Income taxes, net of refunds$245$11,186
Supplemental schedule of non-cash investing and financing activities:
Financing lease obligations$3,408$3,004
Repurchases of common stock in accounts payable$—$325
Purchases of property and equipment in accounts payable$10,416$937
Consideration for purchase of redeemable noncontrolling interest in accounts payable$—$5,100
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.